Cargando…

Osteoarthritis Research Society International (OARSI): Past, present and future

We provide a detailed account of the origin and establishment of the Osteoarthritis Research Society International (OARSI) and celebrate its history from inception to the current day. We discuss the mission, vision and strategic objectives of OARSI and how these have developed and evolved over the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mobasheri, Ali, Im, Gun-il, Katz, Jeffrey N., Loughlin, John, Kraus, Virginia B., Sandell, Linda J., Berenbaum, Francis, Abramson, Steve, Lotz, Martin, Hochberg, Marc, Pelletier, Jean-Pierre, Madry, Henning, Block, Joel A., Lohmander, L. Stefan, Altman, Roy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718339/ https://www.ncbi.nlm.nih.gov/pubmed/36474983 http://dx.doi.org/10.1016/j.ocarto.2021.100146

Ejemplares similares

Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status?
por: Karsdal, M.A., et al.
Publicado: (2022)

Non-surgical management of hip and knee osteoarthritis; comparison of ACR/AF and OARSI 2019 and VA/DoD 2020 guidelines
por: Sabha, Marwa, et al.
Publicado: (2021)

The OARSI Joint Effort Initiative: Priorities for osteoarthritis management program implementation and research 2024–2028
por: Bowden, Jocelyn L., et al.
Publicado: (2023)

Adherence to the OARSI recommendations for designing, conducting, and reporting of clinical trials in knee osteoarthritis: a targeted literature review
por: Hummer, Charles D., et al.
Publicado: (2022)

The effect of intra-articular extended-release triamcinolone acetonide on OARSI-recommended physical performance measures in adults with bilateral symptomatic knee osteoarthritis
por: Segal, N.A., et al.
Publicado: (2022)

Disease modification in osteoarthritis; pathways to drug approval
por: Katz, Jeffrey N., et al.
Publicado: (2020)

Validity of the Osteoarthritis Research Society International (OARSI) recommended performance-based tests of physical function in individuals with symptomatic Kellgren and Lawrence grade 0–2 knee osteoarthritis
por: Lee, Si-Huei, et al.
Publicado: (2022)

Anterior knee pain following total knee replacement correlates with the OARSI score of the cartilage of the patella
por: Metsna, Vahur, et al.
Publicado: (2014)

Measurement properties of the OARSI core set of performance-based measures for hip osteoarthritis: a prospective cohort study on reliability, construct validity and responsiveness in 90 hip osteoarthritis patients
por: Tolk, Jaap J, et al.
Publicado: (2019)

The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease?
por: Mobasheri, Ali, et al.
Publicado: (2021)

Correction: Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options
por: Lotz, Martin K, et al.
Publicado: (2010)

Advancing osteoarthritis research
por: Madry, Henning
Publicado: (2019)

Biomaterials in orthopaedics: the past and future with immune modulation
por: Im, Gun-Il
Publicado: (2020)

Low adherence to exercise may have influenced the proportion of OMERACT-OARSI responders in an integrated osteoarthritis care model: secondary analyses from a cluster-randomised stepped-wedge trial
por: Moseng, Tuva, et al.
Publicado: (2020)

Regenerative medicine for early osteoarthritis
por: Im, Gun-Il, et al.
Publicado: (2023)

Current status of regenerative medicine in osteoarthritis: stem cells, exosomes, and genes
por: Im, Gun-Il
Publicado: (2021)

Regenerative Therapy for Osteoarthritis: A Perspective
por: Im, Gun-Il, et al.
Publicado: (2020)

Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2013)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2014)

Biomarkers in Osteoarthritis
por: Sandell, Linda J.
Publicado: (2012)

Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers
por: Bay-Jensen, Anne C., et al.
Publicado: (2022)

Osteoarthritis: Novel Molecular Mechanisms Increase Our Understanding of the Disease Pathology
por: Grässel, Susanne, et al.
Publicado: (2021)

Mitochondrial Genome Editing to Treat Human Osteoarthritis—A Narrative Review
por: Zhong, Gang, et al.
Publicado: (2022)

The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis
por: Roos, Ewa M, et al.
Publicado: (2003)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Association of Nicotine with Osteochondrogenesis and Osteoarthritis Development: The State of the Art of Preclinical Research
por: Cai, Xiaoyu, et al.
Publicado: (2019)

Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis
por: Cucchiarini, Magali, et al.
Publicado: (2014)

New horizons and perspectives in the treatment of osteoarthritis
por: Berenbaum, Francis
Publicado: (2008)

COVID-19, osteoarthritis and women's health
por: Mobasheri, Ali
Publicado: (2020)

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
por: Hochberg, Marc C, et al.
Publicado: (2016)

Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease
por: Attur, Mukundan, et al.
Publicado: (2020)

The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
por: Mobasheri, A.
Publicado: (2013)

The Future of Osteoarthritis Therapeutics: Emerging Biological Therapy
por: Mobasheri, A.
Publicado: (2013)

Intersection of Inflammation and Herbal Medicine in the Treatment of Osteoarthritis
por: Mobasheri, Ali
Publicado: (2012)

The quest for the Holy Grail: a disease-modifying osteoarthritis drug
por: Berenbaum, Francis
Publicado: (2007)

Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options
por: Lotz, Martin K
Publicado: (2010)

Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management
por: Henrotin, Yves, et al.
Publicado: (2013)

Articular cartilage and changes in Arthritis: Cell biology of osteoarthritis
por: Sandell, Linda J, et al.
Publicado: (2001)

Biomechanical considerations in the pathogenesis of osteoarthritis of the knee
por: Heijink, Andras, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fc45kmj5ka52ro4kacuohnifqt